Existing-home sales slump as momentum slows in the housing market
The numbers: Existing-home sales fell for the fourth consecutive month, as buyers continue to face major hurdles in the road…
Exxon Mobil plans to cut office workforce by up to 10% a year: report
Exxon Mobil Corp. reportedly plans to reduce its U.S. office workforce by up to 10% a year for the next…
Investors growing more fearful of a Fed mistake
Stocks have slipped, and bonds have rallied, since the Federal Reserve unexpectedly forecast two interest rate hikes in 2023, and…
The new cruise ship rulebook: What to know about booking a trip, getting on board, and other changes
You may have been able to hear the champagne corks pop and cheers resound on June 5 as the Celebrity…
This is where older Americans find the most happiness
Ready for this one? Good things came out of the pandemic. A new study “The Four Pillars of the New…
The housing market is so crazy, this $600,000 ‘horror’ is drawing multiple cash offers and one place where businesses are more likely to require COVID-19 vaccinations for workers
Happy Friday MarketWatchers. Don’t miss these top stories. There’s one place in the U.S. where businesses are far more likely…
Four COVID-19 vaccines are being tested in children and teens. Here’s when different age groups could become eligible for shots.
Moderna’s vaccine is expected to be next authorized in teens, following the Food and Drug Administration’s decision in mid-May to…
The lure of the open road — and the open-air hotel corridor
Just about everyone recognizes that the midcentury-modern noun motel is a portmanteau derived from two pre-existing words: motor (or motorist)…
CDC aligns with WHO on delta COVID variant; experts warn of higher risks of infection and serious illness
The Centers for Disease Control and Prevention has reclassified the delta variant of COVID-19 as one “of concern,” underscoring how much…
CureVac stock drops more than 50% on news trial COVID vaccine 47% effective
Shares of Curevac NV tanked more than 50% in the extended session Wednesday after the pharma company said its trial…